This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Innovator Kiyoto Sakata: Pioneering 8-Azaprostaglandin Derivatives
Introduction: Kiyoto Sakata is an accomplished inventor based in Mishima-gun, Japan, known for his significant contributions to the field of pharmaceuticals. With a keen focus on innovative solutions, he aims to tackle various medical conditions through his patented work.
Latest Patents: Kiyoto Sakata holds a patent for "8-azaprostaglandin derivatives and medical use thereof." This patent includes a pharmaceutical composition comprising a compound with an 8-azaprostaglandin skeleton. His invention is designed for numerous applications, including the prevention and treatment of immunological diseases, asthma, and various other serious health conditions. The compounds exhibit EPagonistic action, offering a promising solution for ailments such as chronic obstructive pulmonary disease, renal insufficiency, and even glaucoma. Additionally, these compounds show potential in accelerating bone formation, making them valuable for treating osteoporosis and other bone-related disorders.
Career Highlights: Throughout his career, Kiyoto Sakata has worked diligently at Ono Pharmaceutical Co., Ltd., where he has developed innovative pharmaceutical solutions. His research has not only garnered him a patent but has also contributed to the advancement of medical science in understanding and treating complex diseases.
Collaborations: Kiyoto has collaborated with notable colleagues such as Tohru Kambe and Toru Maruyama. These partnerships have fostered an environment of teamwork and innovation, leading to the successful development of groundbreaking medicinal compounds.
Conclusion: Kiyoto Sakata’s contributions to the field of pharmaceuticals through his patented work on 8-azaprostaglandin derivatives reflect his commitment to addressing critical health issues. With promising potential in treating various conditions, his innovative efforts mark a significant advancement in medical research and application.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile